Fundraising FoxHealthtech Startups
18,775 companies tagged Healthtech, with their investors and founders.
Petros Pharmaceuticals is a bio-pharmaceutical company working to convert prescription drugs into over-the-counter self-care treatments, allowing consumers access without a physician visit or prescription. It operates in the emerging self-care pharmaceutical market.
0 investors
PetVivo is a veterinary biotech and biomedical device company that adapts human biotech and medical technology into products for the veterinary market. Its lead product, Spryng with OsteoCushion Technology, uses proprietary protein-based biomaterials to manage joint pain, lameness, and osteoarthritis in companion animals such as dogs and horses.
0 investors
Petzey operates a network of virtual veterinary professionals offering on-demand advice and consultations to pet owners for $20 per call. It serves owners of dogs, cats, birds, reptiles, and pocket pets seeking convenient telehealth care for their animals.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Phairify operates a platform connecting physicians to job opportunities and employers to physician candidates, using specialty-specific labor market data to facilitate transparent career matches. The platform serves physicians and healthcare employers seeking efficient, data-driven recruitment and placement.
0 investors
PharmaCyte is a biotechnology company developing Cell-in-a-Box, a live-cell encapsulation technology, to create cellular therapies for cancer, diabetes, and malignant ascites. The company encapsulates genetically engineered human cells to deliver localized drug activation or insulin production.
0 investors
PharmAdva makes the MedaCube, a smart automated pill dispenser that helps patients take prescribed medications correctly and lets caregivers and physicians monitor in-home medication adherence in real time. The device targets people who struggle to manage their medications, supporting independent living and reduced hospitalization.
0 investors
0 investors
Pharmazz is a biopharmaceutical company developing and commercializing therapeutics for critical care and acute medicine, focused on Endothelin-B receptor agonists and resuscitative agents for conditions such as hypovolemic shock, ischemic stroke, and septic shock. Its lead products include Centhaquine (Lyfaquin) for hypovolemic shock and Tyvalzi for cerebral stroke, with operations in the U.S. and India.
0 investors
PharmD Live provides virtual chronic care and medication management services, embedding clinical pharmacists, advanced practice providers, and care managers into healthcare teams alongside AI-powered risk stratification. Its modular programs (CCM, RPM, TCM, BHI, and others) serve medical practices, ACOs, health systems, and payers to support value-based care performance in the U.S.
0 investors
0 investors
0 investors
PhenoVista provides contract research services focused on phenotypic and high-content imaging studies, using quantitative fluorescence microscopy and cell-based disease models to support R&D and drug discovery decisions. It serves life science and biotech researchers.
0 investors
Phield House is an indoor multi-sport facility in Philadelphia that rents space to sports leagues for volleyball, basketball, soccer, dodgeball, and other sports, as well as for fitness classes, private training, and events. The 25,000 square-foot facility offers multiple playing surfaces, meeting rooms, and amenities for youth and adult league organizations.
0 investors
Phigenix develops personalized medicine for cancer, including companion diagnostics and targeted therapies for prostate and breast cancer patients. Its work centers on early detection and targeted inhibition of PAX2 and EN2 oncogenes and a cancer vaccine using Human Beta Defensin-1 (DEFB1) mRNA to direct the immune system against cancer cells.
0 investors
Phio Pharmaceuticals is a clinical-stage biopharmaceutical company developing INTASYL, a proprietary self-delivering siRNA gene silencing technology that makes immune cells more effective at killing cancer cells. Its immuno-oncology pipeline targets cutaneous squamous cell carcinoma (cSCC) and melanoma.
0 investors
0 investors
0 investors
0 investors